换一批
第一作者：
Yingyang,Xu
第一单位：
Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.;Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases, Beijing, 100730, China.;National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, 100730, China.;Centre for Translational Medicine, Peking Union Medical College Hospital, China.
作者：
关键词
ACE2ADAM metallopeptidase domain 17, ADAM17C1 inhibitor, C1–INHCOVID-19Complement systemContact systemCoronavirus disease 2019, COVID-19Hereditary angioedemaMiddle East respiratory syndrome coronavirus, MERS-CoVacute respiratory distress syndrome, ARDSangiotensin-converting enzyme, ACEbradykinin receptor B1, B1Rbradykinin receptor B2, B2Rbradykinin, BKdes-Arg(9)-bradykinin, DABKgranulocyte-colony stimulating factor, GCSFgranulocyte-macrophage colony stimulating factor, GM-CSFhereditary angioedema, HAEhigh-molecular-weight kininogen, HMWKinterleukin-1, IL-1macrophage inflammatory protein, MIPmannose-binding lectin associated serine protease, MASPmannose-binding lectin, MBLsevere acute respiratory syndrome coronavirus 2, SARS-CoV-2transforming growth factor-β, TGF-βtransmembrane serine protease, TMPRSS2tumor necrosis factor γ, TNF-γ
DOI
10.1016/j.waojou.2020.100454
PMID
32834893
发布时间
2020-11-05
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
